BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints
From MaRDI portal
Publication:6629374
DOI10.1002/SIM.9571zbMATH Open1547.62188MaRDI QIDQ6629374
Author name not available (Why is that?)
Publication date: 29 October 2024
Published in: (Search for Journal in Brave)
No records found.
No records found.
This page was built for publication: BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629374)